Treatment of breakthrough and prevention of refractory chemotherapy-induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update

This CPG is an update of the 2016 version. It aims to provide clinicians (physicians, nurse practitioners, physician assistants, nurses, pharmacists, and others) who care for children and adolescents with cancer or undergoing HSCT with up-to-date recommendations for treatment of breakthrough and prevention of refractory CINV.